Effects of Dynamic Cupping on Shoulder Active Range of Motion of Senior Male Handball Athletes

April 7, 2024 updated by: University Fernando Pessoa

Immediate Effects of Dynamic Cupping on Shoulder Active Range of Motion of Senior Male Handball Athletes: A Randomized Controlled Trial

The purpose of this study is to to verify the immediate effects of dynamic cupping on shoulder active range of motion (AROM) of senior male handball athletes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

After completing the questionnaire, 80 senior male handball athletes will be randomly divided into two designated groups, Intervention Group (IG; n = 40) (dynamic cupping therapy) and Control Group (CG; n = 40) (no intervention).

Shoulder AROM (flexion, extension, abduction, adduction, horizontal adduction, horizontal abduction, internal rotation and external rotation movements) will be assessed in both control and intervention groups before (M0) and after (M1) intervention.

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Porto, Portugal, 4200-253 Porto
        • Escola Superior Saúde Fernando Pessoa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy senior handball athletes in competition with at least three training sessions per week.

Exclusion Criteria:

  • history of injury, fracture or surgical intervention in the upper limb in the last six months before the study;
  • vestibular, neurological or cardiorespiratory diseases;
  • reported pain in the upper limb or spine
  • presence of contraindication for cupping (deep venous thrombosis, with active infection or open wound.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
For the dynamic cupping protocol, the participants will be instructed to remain seated on the massage table with their feet supported, and the technique will applied to the entire shoulder (anterior, lateral and posterior face) and surrounding muscles (upper trapezius and pectoralis major). The cupping will be performed using a plastic cupping cup (5,08 cm in diameter) (K.S. Choi Corp®) and a pistol grip hand pump (K.S. Choi Corp®). The dynamic cupping will be performed for ten minutes, at a slow pace, and consists of applying a small amount of massage cream (ATL®) over the entire shoulder (to obtain the ideal sliding surface for cupping application), insufflation of the suction cup, with two pumps, and sliding it in the direction of the muscle fibers around the shoulder and also in the transversal direction.
The dynamic cupping will be performed for ten minutes, at a slow pace, and consisted of applying a small amount of massage cream (ATL®) over the entire shoulder (to obtain the ideal sliding surface for cupping application), insufflation of the suction cup, with two pumps, and sliding it in the direction of the muscle fibers around the shoulder and also in the transversal direction.
No Intervention: Control group
Participants in the CG group will remain at rest, sitting on the massage table for 10 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
active movements of the shoulder
Time Frame: [Time Frame: Change from Baseline (M0) to Immediately after intervention or control (M1)]

Data will be collected in two moments: baseline (M0) and after the intervention/control (M1). The shoulder range of motion will be measured using a universal goniometer.

Participants will be instructed to perform the various active movements of the shoulder on the dominant upper limb. The assessments of the shoulder flexion, extension, abduction and adduction movements will be performed standing up, controlling possible compensations. To assess abduction and horizontal adduction movements, the participants will remain seated on a massage table. Internal and external rotation movements will be assessed on a massage table in supine, without inclination. Measurements will be considered invalid if the participant is compensated with another body part. Three measures will be collected for each movement and the average of the three will be considered.

[Time Frame: Change from Baseline (M0) to Immediately after intervention or control (M1)]

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2024

Primary Completion (Actual)

February 9, 2024

Study Completion (Actual)

February 23, 2024

Study Registration Dates

First Submitted

January 17, 2024

First Submitted That Met QC Criteria

January 17, 2024

First Posted (Actual)

January 26, 2024

Study Record Updates

Last Update Posted (Actual)

April 9, 2024

Last Update Submitted That Met QC Criteria

April 7, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • FISIO-3-29072019

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on cupping

3
Subscribe